Reading medical group sold to global network
The sale will boost imc group’s ambition to become the leading, independent provider of global strategic healthcare communications and consulting services to the pharmaceutical and biotech industries, and extend the combined firm’s expertise across the US and Europe.
Jon Hallows, CEO of Porterhouse Medical, said: “Selling Porterhouse to imc was one of the biggest decisions of my career and the advice and assistance from Rob and his team has been invaluable. The transaction came with its complexities – tidying up subsidiary interests, bringing along a US subsidiary and the extraction of real estate, to name a few.
“Rob Rice and his team at HCR were at our side from the very outset of the transaction and through every step of the process. He also took away the stress of ensuring that the US side of the transaction moved at the same pace that we were working at here in the UK."
Rob Rice said: “Having worked with Porterhouse over the last few years, I was really pleased for Jon and the team when he told me about the offer from imc and I’m delighted to have helped them with the transaction. I wish the larger group every success going forward.”
Rachel Turner, head of HCR's corporate team in Reading, said: “This has been a tough period for many of our clients and our focus has been on helping them to keep business moving so that they emerge in the best position possible. That means changes for some and we’re ready to help them make those changes so that they can continue to thrive or move on to fresh challenges.”
Harrison Clark Rickerbys has more than 500 staff and partners based at offices in Thames Valley, London, Cambridge, Birmingham, Worcester, Cheltenham, the Wye Valley, Hereford and Cardiff.
